ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Astrazeneca 31

Astrazeneca 31 (50UC)

107.75
0.15
( 0.14% )
Updated: 03:46:04

Astrazeneca 31 Financial Summary

The current 50UC market cap is 167.03B. The company's latest EPS is USD 3.8415 and P/E is 27.55.

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 24.38B26.62B37.42B44.35B45.81B
Operating Income 1.59B4.08B-293M3.54B7.89B
Net Income 1.34B3.2B112M3.29B5.96B
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 61.38B66.73B105.36B96.48B101.12B
Total Liabilities 46.78B51.09B66.08B59.43B61.95B
Total Equity 14.6B15.64B39.29B37.06B39.17B

Cash Flow

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 2.97B4.8B5.96B9.81B10.35B
Investing -657M-285M-11.06B-2.96B-4.06B
Financing -1.77B-2.2B3.65B-6.82B-6.57B
Market Cap 167.03B
Price to Earnings Ratio 27.55
Price to Sales Ratio 3.58
Price to Cash Ratio 28.09
Price to Book Ratio 4.19
Dividend Yield -

Share Statistics

Shares Outstanding 1.55B
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 4.9 (4.45%)

Company Info

Company Name Astrazeneca 31
Address 1 francis crick avenue
cambridge CB2 0AA
Website https://
Industry pharmaceutical preparations (2834)